🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#SafetyChampions on MDQA! #PSAW22 #ROSafety JWBurmeister @abhiasolanki Katelyn Atkins, MD, PHD Courtney B Bin Cai Elizabeth Covington Ray Mak, MD Jean Moran PhD Julianne Pollard-Larkin, PhD Ann Raldow, MD, MPH @sprakermdphd marisa kollmeier + MANY OTHERS

doi.org/10.1016/j.rado… CHyLL the LAD! Left anterior descending V15Gy (LADV15) instead of mean heart dose, + baseline heart disease and HTN predicts ↑ major cardiac events Ray Mak, MD Katelyn Atkins, MD, PHD Radiation Medicine Program #cardiooncology #radonc #lungcancer #cardiotoxicity

#CAC detected by #AI in #lungcancer predicts mortality- improving baseline cardiac risk assessment pubmed.ncbi.nlm.nih.gov/35084935/ Ray Mak, MD Danielle Bitterman, MD Hugo Aerts @CSCancerCare Brigham and Women’s Radiation Oncology

Attention medical students interested in oncology or radiation oncology: Radiation Oncology | Dartmouth Cancer Center Medical Student Rural and Diverse (RaD) Scholars Program may be of interest to you.

Star physicist Christian Guthier demonstrating a pathway for #ai validation in #radonc that emphasizes outcome-based validation for intended use case (coronary autoseg > dose > MACE). Look closely and Danielle Bitterman, MD is moderating! AIM @ Harvard Brigham and Women’s Radiation Oncology #astro22

Katelyn Atkins, MD, PHD presenting her great work on mapping risk of multiple arrhythmia classes to cardiac substructure dose exposure. #ASTRO22 Brigham and Women’s Radiation Oncology Cedars-Sinai Danielle Bitterman, MD

🚨Very important analysis on reducing #radiotherapy dose to LAD (V15<10%)🚨 Ray Mak, MD Katelyn Atkins, MD, PHD Can you share with us what brush size was used for contouring LAD (~7mm?) & which cc volume 10% corresponds to?🙏 OncoAlert @joe_deasy Jeff Bradley, MD redjournal.org/article/S0360-…

We are not fooled. Slow down there RAPIDO. "Short-Course Radiation Therapy and the RAPIDO Trial: Too Short, Too Soon?" Krishan Jethwa Dr. Nina Niu Sanford redjournal.org/article/S0360-…

Tumor boards before 8am or after 5pm cause a greater burden for women and those with children. Virtual tumor boards help, but more is needed to help ensure work-life integration for all radiation oncologists. #RadOnc #ASTRO23

Happening now in Room 1 of ASTRO #ASTRO2023! Excited to learn from these leading ladies in cardiotoxicity & see this in the program!

Masterclass on minimising cardiotoxicity risk using cardiac substructure contours, baseline CV risk & sensible endpoints by Katelyn Atkins, MD, PHD at #ASTRO2023 Much progress in recent years but a long way still to go in lung cancer Ray Mak, MD Michael Tjong Carmen Bergom MD PhD Karl Butterworth

Out now in Journal of Clinical Oncology! Our work on clinical trial endpoints & inclusion criteria in GI oncology trials, and how we can better leverage RCTs to demonstrate the value of RT going forward. With William A Hall, MD and Ted Hong. Brief thread below. ascopubs.org/doi/abs/10.120…

Glad I’m not the only one feeling exhausted from multi-D conferences Cancer at Cedars-Sinai Katelyn Atkins, MD, PHD in JAMA Network Open & how factors such as parenthood, gender, time, frequency, and specialty impact #burnout from #tumorboards jamanetwork.com/journals/jaman… Tara Cohen Sukhmani (Suki) Padda MD

Informative podcast with Katelyn Atkins, MD, PHD reviewing #radiation-induced CV disease on #JACCCardioOnc #Pulse! 🔶Spectrum of RT-induced🫀diseases 🔶Overview of modern RT approaches to ⬇️ risk of🫀disease 🔶Future advances to minimize RT toxicity tinyurl.com/2bjfybue

Just out @JACC CardioOncol, we intricately map #radiation exposure from #radiotherapy for #LCSM to different sub-structures of the heart to predict the risk of 5 different classes of #cardiac arrhythmias, pointing to possibly distinct pathophys pathways. sciencedirect.com/science/articl…

Katelyn Atkins, MD, PHD & Ray Mak, MD take cardiac substructure-specific endpoint analysis to new heights in radiotherapy cardiotoxicity research! Alan McWilliam & myself provide some thoughts on the implications of this awesome paper in a linked editorial: jacc.org/doi/10.1016/j.…

And great editorial commentary by Gerard Walls and Alan McWilliam jacc.org/doi/10.1016/j.… Thank you for the insightful discussion of our work and the state of the field! We are indeed “past the point of no return” for mean heart dose… Cancer at Cedars-Sinai Cedars-Sinai Smidt Heart Institute at Cedars-Sinai

👏🏽👏🏽👏🏽 Katelyn Atkins, MD, PHD Cardiac Substructure RT dose assoc with arrhythmia 👉🏽PV V5 ➡️ AFib 👉🏽L circumflex V35 ➡️ A flutter 👉🏽PV V55 ➡️ SVT 👉🏽 RCA V25 ➡️Bradyarrhythmia 👉🏽 L main CA V5 ➡️ VT/asystole Read editorial Gerard Walls jacc.org/doi/full/10.10… #cardiooncology

Katelyn Atkins, MD, PHD presenting on risk of pulmonary artery HTN after definitive RT. Dose to the PA predicts for PAH. We need to refine treatment planning to better spare heart🫀substructures! Ray Mak, MD

Terrific job by Katelyn Atkins, MD, PHD to identifyradiation induced pulmonary🫁hypertension as a conplication of #lungcancer #radiotherapy and dosimeteic predictors of it👏👏👏 Radiationplanning is becoming really complex - and benefitting our patients‼️🙏 #lcsm #radonc #ASTRO24